Skip to content
Operation Infinite Justice – Lifestyle
Author:
ALAR PHARMACEUTICALS INC
Alar Announced Buprenorphine Injectable, ALA-1000, Demonstrated Long-Term Efficacy and Favorable Safety Profile in Canine Osteoarthritis Pain Management
March 16, 2026